Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tert-Butyl Formate SCHEMBL28828203 | 0.85 | TDP1 (0.52) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27833633 | 0.81 | TDP1 (0.48) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27814649 | 0.81 | TDP1 (0.48) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28092916 | 0.80 | TDP1 (0.68) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27473155 | 0.80 | TDP1 (0.68) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28331255 | 0.80 | TDP1 (0.68) | TDP1 | |
| 4,4-Difluoro-Piperidinium SCHEMBL28056908 | 0.79 | TDP1 (0.50) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28823558 | 0.79 | TDP1 (0.45) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28030712 | 0.79 | TDP1 (0.45) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27722006 | 0.78 | TDP1 (0.65) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107501274-B | It can be used as the compound of ATR kinase inhibitor | Votex Pharmaceutical Co., Ltd. (US) | 2019-11-22 | — | — | CN | disclosed |
| CN-107501275-B | It can be used as the compound of ATR kinase inhibitor | Votex Pharmaceutical Co., Ltd. (US) | 2019-11-22 | — | — | CN | disclosed |
| CN-104903325-A | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMA | 2015-09-09 | — | — | CN | disclosed |